158 related articles for article (PubMed ID: 32630339)
1. Fungal Metabolite Asperaculane B Inhibits Malaria Infection and Transmission.
Niu G; Hao Y; Wang X; Gao JM; Li J
Molecules; 2020 Jul; 25(13):. PubMed ID: 32630339
[TBL] [Abstract][Full Text] [Related]
2. Targeting mosquito FREP1 with a fungal metabolite blocks malaria transmission.
Niu G; Wang B; Zhang G; King JB; Cichewicz RH; Li J
Sci Rep; 2015 Oct; 5():14694. PubMed ID: 26437882
[TBL] [Abstract][Full Text] [Related]
3. A novel fungal metabolite inhibits Plasmodium falciparum transmission and infection.
Niu G; Wang X; Hao Y; Kandel S; Niu G; Raptis RG; Li J
Parasit Vectors; 2021 Mar; 14(1):177. PubMed ID: 33761961
[TBL] [Abstract][Full Text] [Related]
4. A randomized feasibility trial comparing four antimalarial drug regimens to induce
Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
Elife; 2018 Feb; 7():. PubMed ID: 29482720
[TBL] [Abstract][Full Text] [Related]
5. Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission.
Paton DG; Childs LM; Itoe MA; Holmdahl IE; Buckee CO; Catteruccia F
Nature; 2019 Mar; 567(7747):239-243. PubMed ID: 30814727
[TBL] [Abstract][Full Text] [Related]
6. Using an antimalarial in mosquitoes overcomes Anopheles and Plasmodium resistance to malaria control strategies.
Paton DG; Probst AS; Ma E; Adams KL; Shaw WR; Singh N; Bopp S; Volkman SK; Hien DFS; Paré PSL; Yerbanga RS; Diabaté A; Dabiré RK; Lefèvre T; Wirth DF; Catteruccia F
PLoS Pathog; 2022 Jun; 18(6):e1010609. PubMed ID: 35687594
[TBL] [Abstract][Full Text] [Related]
7. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Barnes KI; White NJ
Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
[TBL] [Abstract][Full Text] [Related]
8. MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Penna-Coutinho J; da Silva Araújo M; Campos Aguiar AC; Sá PM; Rios CT; Medeiros JF; Pereira DB; Boechat N; Krettli AU
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():150-155. PubMed ID: 34637981
[TBL] [Abstract][Full Text] [Related]
9. Attractive targeted sugar bait: the pyrrole insecticide chlorfenapyr and the anti-malarial pharmaceutical artemether-lumefantrine arrest Plasmodium falciparum development inside wild pyrethroid-resistant Anopheles gambiae s.s. mosquitoes.
N'Guessan R; Camara S; Rowland M; Ahoua Alou LP; Wolie RZ; Zoh MG; N'Guessan B; Tia IZ; Oumbouke WA; Thomas MB; Koffi AA
Malar J; 2023 Nov; 22(1):344. PubMed ID: 37946208
[TBL] [Abstract][Full Text] [Related]
10. The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen.
Niu G; Franc A C; Zhang G; Roobsoong W; Nguitragool W; Wang X; Prachumsri J; Butler NS; Li J
J Biol Chem; 2017 Jul; 292(28):11960-11969. PubMed ID: 28533429
[TBL] [Abstract][Full Text] [Related]
11. The Rare, the Best: Spread of Antimalarial-Resistant Plasmodium falciparum Parasites by
Berry A; Menard S; Nsango SE; Abate L; Concordet D; Tchioffo Tsapi M; Iriart X; Awono-Ambéné PH; Roche B; Morlais I
Microbiol Spectr; 2021 Oct; 9(2):e0085221. PubMed ID: 34668767
[TBL] [Abstract][Full Text] [Related]
12. A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.
Eastman RT; Pattaradilokrat S; Raj DK; Dixit S; Deng B; Miura K; Yuan J; Tanaka TQ; Johnson RL; Jiang H; Huang R; Williamson KC; Lambert LE; Long C; Austin CP; Wu Y; Su XZ
Antimicrob Agents Chemother; 2013 Jan; 57(1):425-35. PubMed ID: 23129054
[TBL] [Abstract][Full Text] [Related]
13. Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.
Abdul-Ghani R; Beier JC
Parasitol Res; 2014 Oct; 113(10):3535-46. PubMed ID: 25185662
[TBL] [Abstract][Full Text] [Related]
14. Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccine.
Lavazec C; Boudin C; Lacroix R; Bonnet S; Diop A; Thiberge S; Boisson B; Tahar R; Bourgouin C
Infect Immun; 2007 Apr; 75(4):1635-42. PubMed ID: 17283100
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
[TBL] [Abstract][Full Text] [Related]
16. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
[TBL] [Abstract][Full Text] [Related]
17. Screening the Pathogen Box for Inhibition of Plasmodium falciparum Sporozoite Motility Reveals a Critical Role for Kinases in Transmission Stages.
Kanatani S; Elahi R; Kanchanabhogin S; Vartak N; Tripathi AK; Prigge ST; Sinnis P
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0041822. PubMed ID: 35943271
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
19. Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
Yipsirimetee A; Tipthara P; Hanboonkunupakarn B; Tripura R; Lek D; Kümpornsin K; Lee MCS; Sattabongkot J; Dondorp AM; White NJ; Kobylinski KC; Tarning J; Chotivanich K
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0173022. PubMed ID: 37338381
[TBL] [Abstract][Full Text] [Related]
20. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
